According to Foresight News, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) has announced its intention to acquire $100 million worth of Ethereum over the next 12 months. The company stated that this move aims to bolster its corporate strategy across cryptocurrency investments, drug development, and asset acquisition.
Propanc Biopharma Plans $100 Million Ethereum Acquisition
--・
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
ETH
4,285.66
-1.39%
Related News
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Relevant Creator
@Binance_News